Kendall Law Group Investigates HealthTronics, Inc. Merger for Shareholders
07 Maio 2010 - 1:50PM
Business Wire
Kendall Law Group is investigating HealthTronics, Inc. (NASDAQ:
HTRN) for shareholders in connection with the proposed sale of the
Company to Endo Pharmaceuticals Holdings Inc. The national
securities firm seeks to determine whether HealthTronics and its
Board breached their fiduciary duties by entering into the
agreement without properly shopping for a deal that would provide
better value for shareholders. If you are an HTRN shareholder and
have information to contribute or would like additional information
about your rights, contact the Kendall Law Group at 877-744-3728 or
by email at skendall@kendalllawgroup.com.
On May 5, 2010, HealthTronics announced that they had entered
into an agreement to be acquired by Endo for $223 million.
According to the agreement, HTRN shareholders will receive $4.85
per share. HTRN stock traded between $4.19 and $4.50 prior to the
economic downturn in the latter part of 2008 and has experienced
steady growth since then. President and CEO, James Whittenburg
recently cited improvements in earnings in the fourth quarter of
2009. The company also touted “continued reinvestment into growth
initiatives” and anticipated “meaningful organic growth in 2011 and
beyond.” Shareholders are encouraged to contact Kendall Law Group
as the tender offer is expected to expire by July 1, 2010.
Kendall Law Group was founded by a former federal judge,
includes a former United States Attorney, prosecutors and
securities lawyers who are experienced in complex securities
litigation. The firm has been counsel in dozens of merger and
acquisition cases nationwide, including some of the largest
transactions in the United States.
Htetf (MM) (NASDAQ:HTRN)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Htetf (MM) (NASDAQ:HTRN)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Htetf (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Kendall Law Group